Tag: Cell Signaling and Communication
SABCS Session Provides Clinical Implications of New Data and Practical Takeaways
The 2024 San Antonio Breast Cancer Symposium (SABCS) concluded with a “View from the Trenches” panel discussing the clinical implications of key findings presented during the symposium. Bringing medical, surgical, and radiation oncology specialists together with a breast cancer thriver turned patient advocate, the conversation explored how these latest findings might alter how clinicians navigate… Continue reading SABCS Session Provides Clinical Implications of New Data and Practical Takeaways
New mechanism discovered that triggers immune response in cells with damaged DNA
A research team has revealed a previously unknown mechanism that triggers an inflammatory immune response in cells when their DNA is damaged. This discovery deepens the understanding of a new type of cell signaling that may lead to more effective treatments for cancer.
FDA Approvals in Oncology: October-December 2024
To help our readers keep track of the cancer therapies approved by the U.S. Food and Drug Administration (FDA), understand their impact for patients, and put them in context of the current therapeutic landscape, Cancer Research Catalyst provides a quarterly review of the latest approvals in oncology from the FDA. The FDA had a busy 2024, issuing… Continue reading FDA Approvals in Oncology: October-December 2024
NEK7 phosphorylation amplifies NLRP3 inflammasome activation downstream of potassium efflux and gasdermin D
Science Immunology, Volume 10, Issue 103, January 2025.
Editors’ Picks, December 2024: Immunosuppression in the Lung, New Mathematical Models, and More
As we ring in 2025, Cancer Research Catalyst wishes you a very Happy New Year! May your 2025 be full of love, connection, and inspiration. As always, we love to keep you connected with inspiring cancer research by sharing this month’s editors’ picks from the 10 American Association for Cancer Research (AACR) journals. December’s holiday… Continue reading Editors’ Picks, December 2024: Immunosuppression in the Lung, New Mathematical Models, and More
Optogenetic Control of Dopamine Receptor 2 Reveals a Novel Aspect of Dopaminergic Neurotransmission in Motor Function
Dopaminergic neurotransmission plays a crucial role in motor function through the coordination of dopamine receptor (DRD) subtypes, such as DRD1 and DRD2, thus the functional imbalance of these receptors can lead to Parkinson’s disease. However, due to the complexity of dopaminergic circuits in the brain, it is limited to investigating the individual functions of each… Continue reading Optogenetic Control of Dopamine Receptor 2 Reveals a Novel Aspect of Dopaminergic Neurotransmission in Motor Function
